BMS response to MHRA recommendations

The medical advisory council of the BMS has reviewed the recommendations issued by the Medicines and Healthcare Products Regulatory Agency (MHRA) on 30 August. The following letter was sent to Dr June Raine, interim CEO of the MHRA.

2019-09-09T13:25:30+01:009 September 2019|

Joint RCOG / BMS / FSRH position on ongoing HRT shortages

The Royal College of Obstetricians and Gynaecologists (RCOG), the British Menopause Society (BMS) and the Faculty of Sexual and Reproductive Health care (FSRH) are receiving multiple queries from women who are unable to access their hormone replacement therapy (HRT) products due to ongoing manufacturing and supply issues.

2019-08-29T06:52:33+01:0029 August 2019|